Data through FY2026 Q3 (Jun 30, 2026)
Shire Human Genetic Therapies Inc.
Company profile for Shire Human Genetic Therapies Inc. covers 34 filings across the reporting window. FY2026 certified median offer: $136,560.
- FY2026 certified median
- $136,560
- Total filings
- 34
- FY2026 25th–75th percentile
- $118,086–$162,436
- Top job title
- Digital Analyst
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 20 | $134,410 | $120,347 | $152,687 |
| FY2025 | 8 | $138,080 | $114,443 | $157,514 |
| FY2026 (Q1–Q3) | 6 | $136,560 | $118,086 | $162,436 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Digital Analyst2 filings
- Product Quality Lead2 filings
- Regulatory Lead2 filings
- Senior Process Validation Engineer I2 filings
- Sr. Validation engineer2 filings
- Automation Engineer1 filings
- Automation Hardware Engineer1 filings
- CMC Submission Lead1 filings
- Director, Head of Manufacturing Science Downstream1 filings
- Director, Quality Risk Management1 filings